| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |